These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3986737)

  • 1. Cyproterone acetate in the treatment of metastatic cancer of the male breast.
    Lopez M
    Cancer; 1985 May; 55(10):2334-6. PubMed ID: 3986737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyproterone acetate in advanced male breast cancer.
    Lopez M; Barduagni A
    Cancer; 1982 Jan; 49(1):9-11. PubMed ID: 6459156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and endocrine effects of cyproterone acetate in postmenopausal patients with advanced breast cancer.
    Willemse PH; Dikkeschei LD; Mulder NH; van der Ploeg E; Sleijfer DT; de Vries EG
    Eur J Cancer Clin Oncol; 1988 Mar; 24(3):417-21. PubMed ID: 2968261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of acne with cyproterone acetate and ethinyl estradiol.
    Palatsi R; Ylöstalo P; Taipale A
    Acta Derm Venereol; 1978; 58(5):449-54. PubMed ID: 82357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum prolactin levels during therapy of prostatic cancer with oestradiol-17 beta-undecylate and cyproterone acetate (author's transl)].
    Spona J; Lunglmayr G
    Wien Klin Wochenschr; 1980 Jul; 92(14):494-7. PubMed ID: 6933738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of advanced prostatic cancer with parenteral cyproterone acetate: a phase III randomised trial.
    Jacobi GH; Altwein JE; Kurth KH; Basting R; Hohenfellner R
    Br J Urol; 1980 Jun; 52(3):208-15. PubMed ID: 7000222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of idiopathic hirsute women with two combinations of cyproterone acetate.
    Salva P; Morer F; Ordoñez J; Rodriguez J
    Int J Clin Pharmacol Res; 1983; 3(2):129-35. PubMed ID: 6237068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibition of ovulation with 35 micrograms of ethinyl estradiol and 2 mg of cyproterone acetate (Diane 35)].
    Spona J; Huber J; Schmidt JB
    Geburtshilfe Frauenheilkd; 1986 Jul; 46(7):435-8. PubMed ID: 3093307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cyproterone/acetate (SH-714) on plasma prolactin in patients with prostatic cancer.
    Holub G; Lunglmayr G; Spona J
    Urol Res; 1981; 9(5):245-7. PubMed ID: 6458145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary oxalate excretion during anti-androgenic therapy.
    Tiselius HG; Varenhorst E; Carlström K; Larsson L
    Invest Urol; 1980 Sep; 18(2):110-1. PubMed ID: 6447675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum levels of prolactin, estradiol, testosterone and sex hormone-binding globulin in women with breast cancer treated with cytostatics and anti-estrogens].
    Grodecka-Gazdecka S; Baron J
    Ginekol Pol; 1986 Dec; 57(12):778-83. PubMed ID: 3570023
    [No Abstract]   [Full Text] [Related]  

  • 12. Combined treatment with buserelin and cyproterone acetate in metastatic male breast cancer.
    Lopez M; Natali M; Di Lauro L; Vici P; Pignatti F; Carpano S
    Cancer; 1993 Jul; 72(2):502-5. PubMed ID: 8319180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal modulation in systemic lupus erythematosus. Preliminary clinical and hormonal results with cyproterone acetate.
    Jungers P; Kuttenn F; Liote F; Pelissier C; Athea N; Laurent MC; Viriot J; Dougados M; Bach JF
    Arthritis Rheum; 1985 Nov; 28(11):1243-50. PubMed ID: 4062999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new association of ethinylestradiol (0.035 mg) cyproterone acetate (2 mg) in the therapy of polycystic ovary syndrome.
    Falsetti L; Dordoni D; Gastaldi C; Gastaldi A
    Acta Eur Fertil; 1986; 17(1):19-25. PubMed ID: 2941960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiandrogens and hirsutism.
    Biffignandi P; Molinatti GM
    Horm Res; 1987; 28(2-4):242-9. PubMed ID: 2969862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of cyproterone acetate in prostate cancer.
    Goldenberg SL; Bruchovsky N
    Urol Clin North Am; 1991 Feb; 18(1):111-22. PubMed ID: 1825143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cancers of the prostate and cyproterone acetate. Value of blood testosterone and PSA levels for treatment surveillance].
    Aubert J; Dore B; Irani J; Bon D
    J Urol (Paris); 1990; 96(8):431-5. PubMed ID: 1707083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects and mechanisms of castration, estrogen anti-androgen, and anti-estrogen-induced regression of accessory sex organ epithelium and muscle.
    Neubauer B; Blume C; Cricco R; Greiner J; Mawhinney M
    Invest Urol; 1981 Jan; 18(4):229-34. PubMed ID: 7451082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term treatment of virilized women with cyproterone acetate (author's transl)].
    Abrahamsson L; Hackl H; Lindström B; Sogn J
    Wien Klin Wochenschr; 1981 Sep; 93(17):552-6. PubMed ID: 6458162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of reverse sequential anti-androgen therapy (cyproterone acetate and ethinyl estradiol) on hematological parameters.
    Parr JH; Seed M; Godsland I; Wynn V
    J Endocrinol Invest; 1987 Jun; 10(3):237-9. PubMed ID: 2957418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.